Stay updated with breaking news from Aipsc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) insider Luis Borges sold 15,597 shares of Century Therapeutics stock in a transaction dated Thursday, March 23rd. The shares were sold at an average price of $3.55, for a total transaction of $55,369.35. Following the completion of the sale, the insider now owns 249,083 shares in the company, […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) insider Luis Borges sold 15,597 shares of the stock in a transaction on Thursday, March 23rd. The shares were sold at an average price of $3.55, for a total value of $55,369.35. Following the transaction, the insider now directly owns 249,083 shares of the company’s stock, valued at […]
Induced pluripotent stem cells (iPSC) are a promising avenue by which cellular therapies may be enhanced. They also represent massive potential in drug tests and gene therapies. Sino Biological has a vast range of iPSC cytokines for R&D.
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) has been given a consensus rating of “Moderate Buy” by the seven ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among […]
More than 70% of stem cell lines derived from human skin cells have damage to their DNA that could compromise their use in research and cell-based therapies.